Kemwell Biopharma

Kemwell Biopharma is a leading contract biologics development and manufacturing organization (CDMO) committed to providing high-quality, cost-effective, and time-efficient solutions to global biopharmaceutical organizations. With state-of-the-art facilities in Bangalore, India, Kemwell Biopharma offers comprehensive services for mammalian cell culture-based products, including monoclonal antibodies, bispecific antibodies, and fusion proteins. Kemwell Biopharma's facilities, designed with technological support from a leading German pharma company, encompass a cGMP drug substance manufacturing area with over 4500L bioreactor capacity and sterile fill and finish areas for cGMP drug product manufacturing.

Kemwell Biopharma is equipped to support novel, bio-better, and biosimilar programs throughout preclinical and clinical development, cGMP clinical manufacturing, and cGMP commercial manufacturing. The Primary address of Kemwell Biopharma is 34th KM Tumkur Road, T-Begur, Nelamangala Taluk, Bangalore, 562123, IN, with an additional location at PO Box 14241, Research Triangle Park, NC 27709, US. Leveraging extensive experience in contract manufacturing and R&D, Kemwell Biopharma has evolved into a 100% biologics CDMO, building upon a legacy of successful collaborations with pharma leaders.

Kemwell Biopharma continues to drive innovation and excellence in the biopharmaceutical industry. The company is dedicated to delivering exceptional value and fostering long-term partnerships. We look forward to completing the company's information soon with the support of the management team. We invite the manager of Kemwell Biopharma to create a customized and exclusive company showcase and product listing on our platform.